Use of cell-free microRNA as potential cancer biomarkers made possible through Droplet Digital™ PCR
Hercules, CA -- July 28, 2015 -- Droplet Digital PCR (ddPCR™) has been shown to be a useful tool for the identification of microRNAs (miRNA) circulating in the blood that could serve as potential cancer biomarkers. A study in the journal Oncotarget further supports these findings and identifies a novel miRNA that shows great potential for breast cancer diagnosis. These findings confirm the potential clinical utility of ddPCR technology to precisely and reliably quantify cell-free miRNAs. The study also emphasizes that sample type as well as its preparation are critical ...
